We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$540M
AUM Growth
-$17.9M
Cap. Flow
-$41M
Cap. Flow %
-7.6%
Top 10 Hldgs %
26.96%
Holding
716
New
62
Increased
152
Reduced
248
Closed
35

Top Buys

Rank Stock Value
1
EWM icon
iShares MSCI Malaysia ETF
EWM
+$10.3M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$9.74M
3
IBM icon
IBM
IBM
+$8.96M
4
MCHI icon
iShares MSCI China ETF
MCHI
+$8.57M
5
LIN icon
Linde
LIN
+$7.04M

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$21.8M
2
STLA icon
Stellantis
STLA
+$20.9M
3
EPHE icon
iShares MSCI Philippines ETF
EPHE
+$11.4M
4
RACE icon
Ferrari
RACE
+$10.4M
5
DB icon
Deutsche Bank
DB
+$9.96M

Sector Composition

Rank Sector Weight
1 Financials 13.08%
2 Consumer Discretionary 12.84%
3 Technology 8.88%
4 Materials 7.83%
5 Industrials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADAP
601
DELISTED
Adaptimmune Therapeutics
ADAP
$537 ﹤0.01%
121
– –
WY icon
602
Weyerhaeuser
WY
$17.3B
$526 ﹤0.01%
17
– –
DE icon
603
Deere & Co
DE
$170B
$519 ﹤0.01%
3
– –
EW icon
604
Edwards Lifesciences
EW
$47.6B
$473 ﹤0.01%
6
– –
IOVA icon
605
Iovance Biotherapeutics
IOVA
$2.23B
$473 ﹤0.01%
20
-374
-95% -$8.51K
BLUE
606
DELISTED
bluebird bio
BLUE
– –
0
– –
CTRA
607
DELISTED
Coterra Energy
CTRA
$468 ﹤0.01%
27
– –
PJP icon
608
Invesco Pharmaceuticals ETF
PJP
$425M
$462 ﹤0.01%
7
– –
DRE
609
DELISTED
Duke Realty Corp.
DRE
$457 ﹤0.01%
13
– –
DLTR icon
610
Dollar Tree
DLTR
$23.1B
$454 ﹤0.01%
5
– –
SAGE
611
DELISTED
Sage Therapeutics
SAGE
$449 ﹤0.01%
6
– –
EPU icon
612
iShares MSCI Peru and Global Exposure ETF
EPU
$534M
$440 ﹤0.01%
12
– –
BLD
613
DELISTED
TopBuild
BLD
$437 ﹤0.01%
4
– –
FHN icon
614
First Horizon
FHN
$12.1B
$437 ﹤0.01%
27
– –
GEO icon
615
The GEO Group
GEO
$4.13B
$434 ﹤0.01%
27
– –
STM icon
616
CALL
STMicroelectronics
STM
$46B
$428 ﹤0.01%
+3
New +$71
EFA icon
617
iShares MSCI EAFE ETF
EFA
$76.4B
$419 ﹤0.01%
6
– –
FM
618
DELISTED
iShares Frontier and Select EM ETF
FM
$402 ﹤0.01%
13
– –
BPMC
619
DELISTED
Blueprint Medicines
BPMC
$401 ﹤0.01%
5
– –
HYS icon
620
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.73B
$401 ﹤0.01%
4
– –
AGN
621
DELISTED
Allergan plc
AGN
$388 ﹤0.01%
2
– –
EMN icon
622
Eastman Chemical
EMN
$7.8B
$381 ﹤0.01%
5
– –
FANG icon
623
Diamondback Energy
FANG
$57.6B
$365 ﹤0.01%
4
– –
TSN icon
624
Tyson Foods
TSN
$20.2B
$363 ﹤0.01%
4
-7,963
-100% -$685K
XHR
625
Xenia Hotels & Resorts
XHR
$1.98B
$345 ﹤0.01%
17
– –
23 24
25
26 27

Similar funds

PC
Plaisance Capital Denver, Colorado $172M AUM 27.11% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
LPWM
Lake Point Wealth Management Rockwall, Texas $176M AUM 11.87% 1-Year Est. Return
ACM
Aquamarine Capital Management New York $170M AUM 15.49% 1-Year Est. Return
HWIS
Hancock Whitney Investment Services New Orleans, Louisiana $157M AUM
LWM
Loveless Wealth Management Billings, Montana $153M AUM 3.63% 1-Year Est. Return
EW
Emerson Wealth Bloomfield Hills, Michigan $153M AUM 16.38% 1-Year Est. Return
GDWAM
Gold Dragon Worldwide Asset Management Central, Hong Kong $151M AUM 54.24% 1-Year Est. Return

Exane Derivatives's Q4 2019 Portfolio in Review

As of Q4 2019, Exane Derivatives held 716 positions worth $540M, down 3.2% from $558M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Exane Derivatives withdrew a net $41M in Q4 2019, closing 35 positions and reducing 248 holdings. Its most notable exit was iShares MSCI Indonesia ETF, an estimated $6.83M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Exane Derivatives opened a new position in IBM worth $9M.

  • Exane Derivatives's largest Q4 2019 buy was IBM: 68,905 shares worth $9M.
  • Exane Derivatives added most to iShares MSCI Malaysia ETF in Q4 2019, an estimated $10.3M increase.
  • Exane Derivatives's biggest Q4 2019 reduction was UBS Group, cutting an estimated $21.8M.
  • Exane Derivatives fully exited iShares MSCI Indonesia ETF in Q4 2019, selling an estimated $6.83M.
  • Exane Derivatives's ten largest holdings make up 27% of its $540M portfolio in Q4 2019.
  • Exane Derivatives opened 62 new positions and closed 35 in Q4 2019.
  • Exane Derivatives's portfolio value fell 3.2% quarter-over-quarter to $540M.

Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.